SenesTech (NASDAQ:SNES) Trading Up 6%
SenesTech Inc (NASDAQ:SNES) shares were up 6% during mid-day trading on Tuesday . The stock traded as high as $1.42 and last traded at $1.41, approximately 171,013 shares traded hands during mid-day trading. A decline of 35% from the average daily volume of 263,549 shares. The stock had previously closed at $1.33.
Separately, ValuEngine raised shares of SenesTech from a “hold” rating to a “buy” rating in a research report on Friday, June 28th.
The firm has a market capitalization of $38.72 million, a PE ratio of -2.23 and a beta of 1.76. The company has a quick ratio of 2.76, a current ratio of 3.83 and a debt-to-equity ratio of 0.07. The stock’s 50-day moving average is $1.50.
In other SenesTech news, CEO Kenneth S. Siegel purchased 696,296 shares of SenesTech stock in a transaction on Tuesday, July 16th. The shares were purchased at an average cost of $1.35 per share, with a total value of $939,999.60. Following the completion of the transaction, the chief executive officer now directly owns 702,558 shares in the company, valued at approximately $948,453.30. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 10.91% of the company’s stock.
A number of hedge funds have recently made changes to their positions in the business. First Interstate Bank acquired a new position in SenesTech during the second quarter valued at approximately $31,000. MRA Associates USA LLC acquired a new position in SenesTech during the second quarter valued at approximately $46,000. Virtu Financial LLC lifted its position in SenesTech by 87.4% during the first quarter. Virtu Financial LLC now owns 56,447 shares of the company’s stock valued at $69,000 after buying an additional 26,322 shares in the last quarter. Bank of New York Mellon Corp acquired a new position in SenesTech during the second quarter valued at approximately $62,000. Finally, BlackRock Inc. acquired a new position in SenesTech during the second quarter valued at approximately $115,000. 6.93% of the stock is currently owned by hedge funds and other institutional investors.
SenesTech Company Profile (NASDAQ:SNES)
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. The company focuses on commercializing ContraPest, a fertility control product for use in controlling rat populations. It is also developing a pipeline of fertility control and animal health products, including feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment.
Recommended Story: What is dividend yield?
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.